Sentences with phrase «file security for»

• In - charge of file access and file security for clients.
• Improved file access and file security for clients.

Not exact matches

Zulilly is also profitable, reporting in its October S1 Securities and Exchange Commission filing net income of $ 2.4 million for the first six months of 2013, compared to a net loss of $ 4 million for the same six months a year earlier.
The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws.
However, for big companies, expensive software's are needed to increase the security and protection of confidential files and transactions.
«Texthelp has in place continuous automated security tests for Browsealoud, and these detected the modified file and as a result the product was taken offline,» claimed chief technology officer Martin McKay.
In 2015, a private contractor for the National Security Agency took home classified files and put them on his home computer.
The class action, filed in United States District Court, for the District of Illinois, Eastern Division, is on behalf of a class consisting of investors who purchased or otherwise acquired Akorn's securities between March 1, 2017 through February 26, 2018, both dates inclusive (the «Class Period»), seeking to recover damages caused by defendants» violations of the federal securities laws and to pursue remedies under Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b - 5 promulgated thereunder, against the Company and certain of its top securities between March 1, 2017 through February 26, 2018, both dates inclusive (the «Class Period»), seeking to recover damages caused by defendants» violations of the federal securities laws and to pursue remedies under Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b - 5 promulgated thereunder, against the Company and certain of its top securities laws and to pursue remedies under Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b - 5 promulgated thereunder, against the Company and certain of its top Securities Exchange Act of 1934 and Rule 10b - 5 promulgated thereunder, against the Company and certain of its top officials.
If you need more advanced document management services, look for hosted solutions that provide automatic e-mail notification in the event of any changes, user authentication for enhanced security, digital signatures, targeted and custom solutions for your industry, multimedia filing so that you can intelligently integrate video, images, and text - based documents, and enhanced data encryption for more secure emailing and remote document access.
• WatchGuard, an Allen, Texas - based security video company, filed for a $ 75 million IPO.
Like TaxAct, TurboTax noticed that the Social Security and Medicare taxes reported on my W - 2 were too high, but TurboTax took the extra step of telling me that I was entitled to a refund from my employer — and then told me what to do about it (ask my employer for a refund and a new W - 2, and then file my tax return).
Within the «risks» section of GoPro's S - 1 filing with the Securities and Exchange Commission, the company listed that one of its biggest concerns for its ongoing success would be the loss of Woodman.
The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
Online radio station Pandora increased the share price for its initial public offering today, bringing the company's valuation to nearly $ 2 billion, according to a recent filing with the Securities and Exchange Commission.
By law, US banks are required to file reports for any transaction over $ 10,000, including the account holder's name, account number, address, and Social Security number.
Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.
While the company failed to return a request for comment, in its S - 1 filing with the U.S. Securities and Exchange Commission, it recently cited Brexit as a major risk factor.
In an SEC filing, the company said that the $ 1.5 million went toward security - related costs and expenses for Ellison's «residence.»
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
In the second quarter of 1999, 139 companies filed an S - 1 with the Securities and Exchange Commission; for the same quarter of 2001, that number fell to 26.
Citing sources with knowledge of the matter, Bloomberg writes that the Palo Alto company has secretly filed paperwork for an IPO with the US Securities and Exchange Commission.
People need to be aware that, when they file for Social Security, they are making a pension election and they are locked in, he added.
Because this information is found on proxy statements that companies issue at different times throughout the year, some totals reflect security costs for either 2015 or 2016, depending on when they most recently filed.
A document filed Thursday with the Securities and Exchange Commission shows that Sandberg has transferred 590,000 shares of Facebook stock, which Recode reports is worth nearly $ 100 million, to a fund she uses for charitable giving.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
Another first for Bitcoin, but an ignominious one: The Securities and Exchange Commission has filed its first fraud lawsuit involving the virtual currency, claiming it was used in a Ponzi scheme.
Diverging from the Obama administration's approach to the issue, which relied largely on filing complaints to the World Trade Organization (WTO), Trump ordered a probe under Section 232 of the Trade Expansion Act of 1962, which lets the president impose restrictions on imports for reasons of national security.
Internet Security Alliance Resources include Common Sense Guide to Cyber Security for Small Businesses, a free downloadable 37 - page PDF file with information and real - life examples.
Lattice Semiconductor Corp. said in a filing Friday it will seek Trump's approval for its proposed $ 1.3 billion sale to Canyon Bridge Capital Partners, gambling that the former real estate dealmaker will approve the tie - up against the advice of the Committee on Foreign Investment in the United States (CFIUS), which scrutinizes foreign deals for national security concerns.
The system scans every file for sensitive elements such as credit card and Social Security numbers.
• Zscaler, a San Jose, Calif. - based cloud security firm, filed for an $ 100 million IPO.
In a filing with the U.S. Securities and Exchange Commission on Wednesday, Disney ran through a list of Iger's accomplishments as CEO in 2015, including «record - breaking enthusiasm» for Star Wars: The Force Awakens, as well as other box office hits such as Pixar's Inside Out and Marvel's Avengers sequel.
Problem: Handling crucial files on the road Solution: A Web site for storing them Payoff: Bypassing the cost and security risks of laptops
The securities litigation firm of Powers Taylor LLP plans to investigate the sale and file a lawsuit to block its progress until a higher price can be obtained for shareholders.
Hudson River Trading, a huge high - frequency trading firm that is responsible for about 5 % of all US stock trading, filed a letter to the Securities and Exchange Commission on Thursday, and it's a pretty brutal takedown of the proposal.
For its fiscal year 2015, ended June 30, it had $ 319 million in total revenue, and $ 6.7 million in profit, according to its IPO filing with the Securities and Exchange Commission.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The proposed amendment to Chapter 45 by adding Section 30 (21 VAC 5-45-30) provides for a notice filing for securities issuers that are using federal Regulation A for offerings up to $ 50 million in a 12 - month period.
The Securities Division is now proposing rules to require the filing of a notice filing form, a consent to service of process, and the fees that would otherwise be required in connection with the registration of these securities offerings but for preemption by the Securities and Exchange CSecurities Division is now proposing rules to require the filing of a notice filing form, a consent to service of process, and the fees that would otherwise be required in connection with the registration of these securities offerings but for preemption by the Securities and Exchange Csecurities offerings but for preemption by the Securities and Exchange CSecurities and Exchange Commission.
The Washington Securities Division is planning to propose rules to preserve filing requirements in connection with offerings of securities to be made under Tier 2 of the Securities and Exchange Commission's newly adopted rules for Regulation A Securities Division is planning to propose rules to preserve filing requirements in connection with offerings of securities to be made under Tier 2 of the Securities and Exchange Commission's newly adopted rules for Regulation A securities to be made under Tier 2 of the Securities and Exchange Commission's newly adopted rules for Regulation A Securities and Exchange Commission's newly adopted rules for Regulation A offerings.
-- Credit freezes on the big three agencies — IRS PIN security for filing taxes — Minimal to no social media footprint — Pay cash as much as possible
For example, my full retirement age is 67 and if I claim at age 62, the earliest age at which I can file for Social Security benefits, my benefit will be equivalent to 70 % of my full retirement age benefFor example, my full retirement age is 67 and if I claim at age 62, the earliest age at which I can file for Social Security benefits, my benefit will be equivalent to 70 % of my full retirement age beneffor Social Security benefits, my benefit will be equivalent to 70 % of my full retirement age benefit.
Factors that could cause or contribute to actual results differing from our forward - looking statements include risks relating to: failure of DBRS to rate the Notes at the anticipated ratings levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing risks; and other risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.
It's that, for a brief moment, you get to be a Have, filing past the miserable Have Nots in the general security line.
Important factors that could cause actual results to differ from OnDeck's forward - looking statements are the risks that OnDeck may not be able to manage its anticipated or actual growth effectively, that its credit models do not adequately identify potential risks, and other risks, including those under the heading «Risk Factors» in OnDeck's Annual Report on Form 10 - K for the year ended December 31, 2016, its Quarterly Reports for the quarters ended June 30 and September 30, 2017 and in other documents that OnDeck files with the Securities and Exchange Commission, or SEC, from time to time which are available on the SEC website at www.sec.gov.
The company announced Monday that it had filed its paperwork with the U.S. Securities and Exchange Commission for an initial public offering.
The company had filed its draft red herring prospectus (DRHP) with India's securities market regulator SEBI for an Initial Public Offering (IPO), in August last year.
Nine plaintiffs including the Securities Industry and Financial Markets Association (SIFMA), the Financial Services Institute, the Financial Services Roundtable, the U.S. Chamber of Commerce, the Insured Retirement Institute and four Texas groups, including the Texas Association of Business, filed a similar lawsuit on June 2 in the U.S. District Court for the Northern District of Texas.
Until disclosures last month that Comey had maintained a file of memos detailing his communications with Trump, including a February meeting in which the president allegedly pressed the then - director to shut down the bureau's investigation of former national security adviser Michael Flynn, the former director had been at the center of firestorm for his pre-election handling of the Hillary Clinton email investigation.
Cigna Corp. began its pursuit of Express Scripts Holding Co. in October 2017, not waiting for regulators to rule on a separate deal between CVS Health Corp. and Aetna Inc., the Bloomfield health insurer said in a filing with securities regulators.
a b c d e f g h i j k l m n o p q r s t u v w x y z